Short Interest in The Oncology Institute, Inc. (NASDAQ:TOIIW) Drops By 50.8%

The Oncology Institute, Inc. (NASDAQ:TOIIW) saw a large decrease in short interest during the month of May. As of May 15th, there was short interest totaling 5,294 shares, a decrease of 50.8% from the April 30th total of 10,750 shares. Based on an average daily volume of 3,547 shares, the days-to-cover ratio is currently 1.5 days.

Oncology Institute Stock Performance

Shares of NASDAQ TOIIW remained flat at $0.05 during midday trading on Wednesday. 2,211 shares of the stock traded hands, compared to its average volume of 15,307. Oncology Institute has a 52-week low of $0.03 and a 52-week high of $0.27. The firm’s 50 day moving average is $0.05 and its 200 day moving average is $0.10.

Oncology Institute Company Profile

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies.